{"nctId":"NCT01932112","briefTitle":"Adenosine Effect on Persistent Pulmonary Vein Isolation Line Evaluation (APPLE Trial)","startDateStruct":{"date":"2012-11"},"conditions":["Atrial Fibrillation","Persistent Common Pulmonary Vein"],"count":378,"armGroups":[{"label":"adenosine arm","type":"OTHER","interventionNames":["Drug: Adenosine arm"]}],"interventions":[{"name":"Adenosine arm","otherNames":["APPLE"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosed atrial fibrillation\n* recurrence of symptomatic atrial fibrillation in spite of Antiarrhythmic drug use\n* written informed consent\n\nExclusion Criteria:\n\n* intracardiac thrombus\n* pregnancy","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Reconnection of Pulmonary Vein Electrogram After Adenosine Infusion","description":"After pulmonary vein isolation, 20mg Intracardiac adenosine will be given to treatment group, will evaluate pulmonary vein reconnection.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"92","spread":null}]}]}]},{"type":"SECONDARY","title":"Atrial Fibrillation Recurrence","description":"At 1 month, 3 month, 6 month and 12 months post ablation routine clinic visits, will perform electrocardiographically documented by electrogram (At 1,3,6,12 months post ablation) and Holter monitoring (At 12 months post ablation)","classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":378},"commonTop":[]}}}